Studies have found that heterozygous mutations in GBA1 can lead to decreased GCase activity, resulting in the accumulation of glycosphingolipids, which are believed to contribute to the pathogenesis of PD by impairing autophagic processes and promoting the aggregation of α-synuclein (1). Here, GBA1 is linked to Parkinson disease.